StockTipsArenaBeta

BUY Strides Pharma Science Limited — Rajesh Satpute

BUYStrides Pharma Science Limited

byRajesh SatputeHorizon: Swing (≤2wk)29 Jun 2026via CNBC Awaaz.

Entry₹1,100Stated
Target₹1,150
Total upside +4.55% (call closed)
Stop loss₹1,080-1.82% risk
Exit₹1,0808 Jul 2026, 2:15 pm
Stop-loss hit-1.82%
Follow Rajesh Satpute for new calls(30% target hit, 137 closed calls)Get alertsWatch STAR for new buy/sell callsGet alertsSee 133 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Jul 2026
1 supporting0 opposing
Supports the BUY call (1)

Strides Pharma Science Ltd is partnering with Ascent Capital to unlock value in its Pivot Path initiative, suggesting a strategic move for value creation.

BSE · Company Update·27 Jun · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.